Cargando…

Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment

Detalles Bibliográficos
Autor principal:	Kwon, Ja-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755465/ https://www.ncbi.nlm.nih.gov/pubmed/34802215 http://dx.doi.org/10.3350/cmh.2021.0359

Ejemplares similares

Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease
por: Del Barrio, María, et al.
Publicado: (2023)

Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
por: Ocker, Matthias
Publicado: (2020)

Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
por: Lee, Seung Mi, et al.
Publicado: (2022)

Nuclear spindles pave the way to metastasis
por: Hensley, Patrick J., et al.
Publicado: (2017)

Paving the way toward better peer review
Publicado: (2016)

Clearing the radiotherapy backlog: innovation to pave the way
por: The Lancet Oncology
Publicado: (2022)

Paving the Way to Unveil the Diversity and Evolution of Phage Genomes
por: Reyes, Alejandro, et al.
Publicado: (2020)

In Vivo Biomarker Imaging: Paving the Way for Precision Medicine
por: Liu, Guanshu, et al.
Publicado: (2023)

Paving the Road Towards Non-Invasive Molecular Imaging
por: Fijneman, Remond J.A.
Publicado: (2006)

Paving the way for new model of oral health care
por: Pandit, Inder Kumar
Publicado: (2016)

Paving the way to metastasis
por: Van Epps, Heather L.
Publicado: (2005)

Sugar-Coated Proteins Pave the Way to Improving Pancreatic Cancer Diagnosis
por: Korc, Murray
Publicado: (2016)

Molecular and Cellular Advances in Endometriosis Research: Paving the Way for Future Directions
por: Laganà, Antonio Simone, et al.
Publicado: (2023)

Refined Diagnostic Protocol for Diabetic Polyneuropathy: Paving the Way for Timely Detection
por: Oh, Byung-Mo
Publicado: (2023)

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
por: Song, Byeong Geun, et al.
Publicado: (2023)

Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes
por: El Jamaly, Hydar, et al.
Publicado: (2022)

Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
por: Koralegedara, Iresha Sandamali, et al.
Publicado: (2022)

Bronchoscopic management of peripheral pulmonary lesions: robotic approach paves the way to the future
por: Mondoni, Michele, et al.
Publicado: (2019)

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
por: Kuo, Hann-Chorng
Publicado: (2020)

In pursuit of a flawless aphrodite: paving the way to scarless oncoplastic breast surgery
por: Zhu, Liling, et al.
Publicado: (2019)

Blocking tumor necrosis factor paved the way for targeted therapeutics in inflammatory diseases
por: Chu, Cong-Qiu
Publicado: (2021)

Eosinophil Extracellular Traps Pave the Way for the Identification of Novel Therapeutics in Severe Asthma
por: Lee, Ji-Hyang, et al.
Publicado: (2022)

The PHD2 oxygen sensor paves the way to metastasis
por: Kuchnio, Anna, et al.
Publicado: (2015)

Paving the Way for Apollo 11
por: Harland, David M
Publicado: (2009)

Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial
por: Schechter, Meir, et al.
Publicado: (2020)

Eyeing non-alcoholic fatty liver disease: The noninvasive way
por: Gude, Dilip
Publicado: (2011)

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

Cardiomyocyte proliferation: paving the way for cardiac regenerative medicine without stem cell transplantation
por: Ventura, Carlo
Publicado: (2010)

SARS-CoV-2 Infection: Paving Way for Sleep Disorders in Long Term!
por: Gupta, Ravi, et al.
Publicado: (2021)

Special Issue “Emerging Virus Infections in Adverse Pregnancy Outcomes”
por: Pomar, Léo, et al.
Publicado: (2022)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets
por: Maciejewski, Mateusz, et al.
Publicado: (2017)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

An analysis of polygenic risk scores for non-alcoholic fatty liver disease
por: Jun, Dae Won
Publicado: (2021)

Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?
por: Van Brussel, Ilse, et al.
Publicado: (2013)

Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations
por: Kumar, Ramesh, et al.
Publicado: (2019)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

The growing burden of non-alcoholic fatty liver disease on mortality
por: Cho, Ju-Yeon, et al.
Publicado: (2023)

Optimal diagnosis and management of non-alcoholic fatty liver disease
Publicado: (2022)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Chuah, Kee-Huat, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nt4728rjm3ivbe9l7r07g1pni1